A Drug-drug Interaction Study of Avapritinib and Midazolam

Clinical trial NCT04908176 · COMPLETED

Trial details

NCT number: NCT04908176
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors GIST Non-resectable Advanced Solid Tumors Recurrent or Unresectable Central Nervous System (CNS) Tumors

Start date: 2022-08-24
Primary completion: 2024-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.